Brief: Biomerieux Receives CE-Marking Of VIDAS TBI

Biomerieux SA

13/10/2023 06:07

Oct 13 (Reuters) - Biomerieux SA  BIOX.PA :
    * CE-MARKING OF VIDAS® TBI (GFAP, UCH-L1), A TEST FOR
IMPROVED
ASSESSMENT  OF PATIENTS WITH MILD TRAUMATIC BRAIN INJURY,
INCLUDING CONCUSSION

Source text for Eikon: https://tinyurl.com/bd7ju3um
Further company coverage:  BIOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))